# A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

> **NCT00185419** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 842 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Yasmin
- **DRUG:** Marvelon

## Key facts

- **NCT ID:** NCT00185419
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 842 (ACTUAL)
- **Last updated:** 2009-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185419, "A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00185419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*